Lyme disease antiscience
Lancet Infect Dis
.
2012 May;12(5):362; author reply 362-3.
doi: 10.1016/S1473-3099(12)70054-3.
Author
Carl Tuttle
PMID:
22541626
DOI:
10.1016/S1473-3099(12)70054-3
No abstract available
Publication types
Letter
Comment
MeSH terms
Anti-Bacterial Agents / administration & dosage*
Borrelia burgdorferi*
Consumer Advocacy / ethics*
Humans
Lyme Disease / drug therapy*
Physicians / ethics*
Professional Misconduct / ethics*
Substances
Anti-Bacterial Agents